科伦博泰生物-B（股票代码：06990）正式披露了其2025年度的财务与业务进展。报告期内，公司成功实现了多款创新产品的商业化上市，标志着其研发成果进入收获期。与此同时，公司构建的梯队化产品管线布局完善，后续增长动力充足，展现出强劲的发展潜力，为未来的持续飞跃奠定了坚实基础。
科伦博泰生物-B（股票代码：06990）正式披露了其2025年度的财务与业务进展。报告期内，公司成功实现了多款创新产品的商业化上市，标志着其研发成果进入收获期。与此同时，公司构建的梯队化产品管线布局完善，后续增长动力充足，展现出强劲的发展潜力，为未来的持续飞跃奠定了坚实基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.